ME
MET
Financial ServicesMetLife, Inc.
Insurance - Life
Total Trades
35
Unique Traders
3
Purchases / Sales
18/17
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Jan 29, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $77.67 | $72.07 | -7.2% | -6.1% | |
Jan 23, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $75.27 | $79.10 | +5.1% | +5.1% | |
Jan 22, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $76.37 | $79.10 | +3.6% | +3.5% | |
Jan 22, 2026 | Rohit KhannaD | Stock | Sell | $15,001 - $50,000 | $76.37 | $79.10 | +3.6% | +3.5% | |
Jan 13, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $76.53 | $77.36 | +1.1% | +2.9% | |
Nov 10, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $76.63 | $79.25 | +3.4% | +2.5% | |
Nov 6, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $75.43 | $78.10 | +3.5% | +1.2% | |
Nov 3, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $78.64 | $77.51 | -1.4% | -1.5% | |
Sep 29, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $80.90 | $77.21 | -4.6% | -8.1% | |
Aug 26, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $79.86 | $79.14 | -0.9% | -3.2% | |
Aug 6, 2025 | Gilbert CisnerosD | Stock | Sell | $1,001 - $15,000 | $74.87 | $78.38 | +4.7% | +2.4% | |
Aug 4, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $73.73 | $79.99 | +8.5% | +6.5% | |
Jul 11, 2025 | Ritchie John TorresD | Stock | Sell | $1,001 - $15,000 | $76.56 | $75.72 | -1.1% | -3.3% | |
Jul 1, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $79.90 | $74.83 | -6.3% | -8.7% | |
Jun 23, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $78.46 | $77.29 | -1.5% | -7.2% | |
Apr 15, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $71.11 | $79.28 | +11.5% | +1.6% | |
Apr 9, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $73.59 | $76.71 | +4.2% | +1.4% | |
Jan 24, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $83.61 | $79.23 | -5.2% | -3.9% | |
Jan 24, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $83.61 | $79.23 | -5.2% | -3.9% | |
Jan 23, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $84.32 | $79.23 | -6.0% | -4.4% | |
Jan 23, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $84.32 | $79.23 | -6.0% | -4.4% | |
Jan 22, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $83.34 | $79.23 | -4.9% | -3.9% | |
Jan 22, 2025 | Rohit KhannaD | Stock | Buy | $15,001 - $50,000 | $83.34 | $79.23 | -4.9% | -3.9% | |
Jan 21, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $84.43 | $80.92 | -4.2% | -5.4% | |
Jan 21, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $84.43 | $80.92 | -4.2% | -5.4% | |
Jan 17, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $84.34 | $79.91 | -5.2% | -7.3% | |
Jan 16, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $83.47 | $79.91 | -4.3% | -7.3% | |
Jan 16, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $83.47 | $79.91 | -4.3% | -7.3% | |
Jan 15, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $82.54 | $79.91 | -3.2% | -6.0% | |
Jan 14, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $81.47 | $80.53 | -1.1% | -5.9% | |
Jan 13, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $79.60 | $80.92 | +1.6% | -2.1% | |
Dec 18, 2024 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $76.57 | $84.34 | +10.1% | +7.9% | |
Dec 16, 2024 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $80.41 | $82.54 | +2.6% | +4.6% | |
Jul 21, 2015 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $35.94 | $32.67 | -9.1% | -5.4% |
Recent News
MetLife Inc (MET) Q4 2025 Earnings Call Highlights: Strong Financial Performance and Strategic ...
Yahoo-Invalid Date
MetLife Tops Fortune List As Investors Weigh Mixed Earnings Picture
Yahoo-Invalid Date
MetLife Q4 Earnings Beat Estimates on Increasing Volumes
Yahoo-Invalid Date
6 Analysts Have This To Say About MetLife
Benzinga-Invalid Date
MetLife Inc. stock underperforms Thursday when compared to competitors
MarketWatch-Invalid Date